Immunomodulation: The next target of mesenchymal stem cell-derived exosomes in the context of ischemic stroke.

Shan, Xiao-Qian; Luo, Yong-Yin; Chang, Jun; Song, Jing-Jing; Hao, Nan; Zhao, Lan

Shan, Xiao-Qian; Luo, Yong-Yin; Chang, Jun; Song, Jing-Jing; Hao, Nan; Zhao, Lan.

Afiliação

Shan XQ; First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin 300381, China.
Luo YY; National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, Tianjin 300381, China.
Chang J; First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin 300381, China.
Song JJ; National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, Tianjin 300381, China.
Hao N; First Teaching Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin 300381, China.
Zhao L; National Clinical Research Center for Chinese Medicine Acupuncture and Moxibustion, Tianjin 300381, China.

World J Stem Cells ; 15(3): 52-70, 2023 Mar 26.

Article em En | MEDLINE | ID: mdl-37007453

Palavras-chave

Exosome therapy; Exosomes; Immunomodulation; Inflammation; Ischemic stroke; Mesenchymal stem cells

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: World J Stem Cells Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google